
    
      This is a three-month study where baseline information is collected at the first visit and
      then each patient is started on treatment with testosterone supplementation and either
      anastrozole or placebo. Lab tests, seizure frequency, sexual function and mood will be
      monitored on a monthly basis.
    
  